(Alliance News) - Alliance Pharma PLC on Friday said it expects to report 2024 profit broadly in line with the year before, despite a decline in annual revenue.

The downgrade comes after the company reported full-year revenue that fell 4% below market expectations, reflecting an underperformance in the second half of the year.

Alliance Pharma said that expected revenue fell, dragged down by consumer healthcare, and stuck to its guidance for the year.